The Asian Development Bank (ADB) signed an $8 million loan with Imexpharm Corporation to help the company sustain its production of generic medicines despite global supply disruptions caused by the coronavirus disease (COVID-19) pandemic.
More
The Asian Development Bank (ADB) signed an $8 million loan with Imexpharm Corporation to help the company sustain its production of generic medicines despite global supply disruptions caused by the coronavirus disease (COVID-19) pandemic.
More